Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Establishing a Rationale for Compounding Hormone Replacement Therapy

Author(s):  Biundo Bruce

Issue:  May/Jun 2018 - Volume 22, Number 3
View All Articles in Issue

Page(s):  190-195

Establishing a Rationale for Compounding Hormone Replacement Therapy Page 1
Establishing a Rationale for Compounding Hormone Replacement Therapy Page 2
Establishing a Rationale for Compounding Hormone Replacement Therapy Page 3
Establishing a Rationale for Compounding Hormone Replacement Therapy Page 4
Establishing a Rationale for Compounding Hormone Replacement Therapy Page 5
Establishing a Rationale for Compounding Hormone Replacement Therapy Page 6

Download in electronic PDF format for $75

Abstract:  Why compound bioidentical hormones? Are there no similar commercial products? What is unique about the options compounding pharmacists offer compared with what is out in the marketplace? These are questions that physicians and other practitioners are asking, and it is very important that we have intelligent, well-thought answers when we respond. Times have changed, and the challenges we face today in marketing our compounded therapies are not the same as those of twenty years ago. Premarin is no longer at the top of the heap, and there are topical, commercial products that contain bioidentical estradiol, and capsules that contain the same progesterone that we use. Our compounding advantage comes from our abilities to prepare unique patient-specific products, and, very importantly, from our growing understanding of hormone receptors; we now know there are two main estrogen receptors, 1) estrogen receptor alpha and 2) estrogen receptor beta, and the growing knowledge base associated with the discovery of estrogen receptor beta is quite significant.

Related Keywords: Bruce Biundo, RPh, FACA, bioidentical hormone replacement therapy, women, estrogen receptor alpha, estrogen receptor beta, menopause, topical preparations, regulation, regulatory approval, estradiol, estriol, breast cancer, testosterone, mood, sexual function, female sexual dysfunction, androgens, libido, hot flashes, vasovagal syndrome, estrogen balance, hysterectomy, bone density

Related Categories: HRT, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
May/Jun 2018
Pg. 190-195

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
Jan/Feb 2024
Pg. 22-27

Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
Mar/Apr 2002
Pg. 142-146

Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
Sep/Oct 2001
Pg. 336-338

Hormone Replacement Therapy, Part 2: Estrogen Defined
Lorentzen Jean
Nov/Dec 2001
Pg. 460-461

Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Vigesaa Kristy A
, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
Jul/Aug 2004
Pg. 313-319

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Reed-Kane Dana
Sep/Oct 2001
Pg. 332-335

View Sample
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris
, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010
Pg. 165-170

Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Girouard Lorinda G
, Holm Richard C
May/Jun 2001
Pg. 218-220

Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
Jan/Feb 2002
Pg. 50-54

Estrogen Replacement: A Review of Current Literature
Parazewski Kevin
Sep/Oct 2001
Pg. 346-350

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D
, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2011
Pg. 290-300

Return to Top